mianserin   Click here for help

GtoPdb Ligand ID: 135

Synonyms: (+-)-athymil | Norval® | ORG GB 94
Approved drug
mianserin is an approved drug
Compound class: Synthetic organic
Comment: The approved drug mianserin is a racemic mixture of two enantiomers. The structure shown here does not specify stereochemistry and represents the mixture.
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: mianserin

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 0
Rotatable bonds 0
Topological polar surface area 6.48
Molecular weight 264.16
XLogP 3.54
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
Isomeric SMILES CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
InChI InChI=1S/C18H20N2/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19/h2-9,18H,10-13H2,1H3
No information available.
Summary of Clinical Use Click here for help
Used in the treatment of major depressive disorder. There is no information regarding approval for medical use of mianserin on the US FDA website. Individual national agencies may have granted marketing approval.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
The exact mechanism of action of mianserin is not well understood, although its action as an antidepressant is likely due to its antagonism of alpha-adrenergic receptors, histmine H1 receptors and several types of serotonin receptors.